ArticleInfectious agents and cancer2023

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation.

Jianming Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.